Innovation in Regulatory Science Awards

BWF's Innovation in Regulatory Science Awards provides up to $500,000 over five years to academic investigators developing new methodologies or innovative approaches in regulatory science that will ultimately inform the regulatory decisions the Food and Drug Administration (FDA) and others make. The program especially encourages applications from those seeking to advance regulatory science approaches that will expedite the realization of equitable clinical outcomes. Applicants must hold a faculty or adjunct faculty appointment at a non-profit institution in the U.S. or Canada, which may include degree-granting institutions, research institutes, and teaching hospitals affiliated with academic degree-granting institutions. The program seeks to support innovative methodologies that address critical gaps in regulatory science and improve the evidence base for regulatory decision-making across various domains including drug development, medical devices, and public health policy.